Skin & Anti-Aging

Hexapeptide-11

Hexapeptide-11 (Peptamide-6) is a yeast fermentate-derived hexapeptide that stimulates fibroblast production of collagen, fibronectin, and laminin, and upregulates desmosome proteins involved in skin barrier integrity.

C36H57N7O8SMolar mass: 735.90 g/mol

⚠ Research & Educational Use Only. Hexapeptide-11 is a research chemical documented here for scientific education. All information references peer-reviewed literature and preclinical/clinical study data. Not for human consumption. Not medical advice. Consult a licensed researcher or healthcare professional before any laboratory use.

Medically reviewed by Dr. Amanda Reid, MDWritten by the KnowYourPeptide Research TeamLast updated April 2026
Our editorial standards →
Key Takeaways
  • Stimulates fibroblast synthesis of collagen, fibronectin, and laminin — structural ECM proteins critical for skin firmness
  • Upregulates desmosome proteins (DSP, DSG) — reinforces cell-cell adhesion in the epidermis
  • Improves skin mechanical properties and resistance to deformation — measured by cutometry in clinical studies
  • Hexapeptide-11 is not FDA-approved for human use. Cosmetic ingredient (INCI: Hexapeptide-11). Regulated as a cosmetic active ingredient globally.

Research At a Glance

  • Stimulates fibroblast synthesis of collagen, fibronectin, and laminin — structural ECM proteins critical for skin firmness
  • Upregulates desmosome proteins (DSP, DSG) — reinforces cell-cell adhesion in the epidermis
  • Improves skin mechanical properties and resistance to deformation — measured by cutometry in clinical studies
  • Anti-aging activity via multiple ECM stimulatory pathways simultaneously (vs peptides targeting a single protein)
Calculate Hexapeptide-11 dose

What is Hexapeptide-11?

Hexapeptide-11 (INCI: Hexapeptide-11; commercial name: Peptamide-6, from Unipex/Lucas Meyer Cosmetics) is a hexapeptide (Pro-Phe-Phe-Leu-Met-Gln) derived from yeast (Saccharomyces cerevisiae) fermentation. It was developed as a multi-pathway ECM stimulatory ingredient, distinguished from most cosmetic peptides by its effects on both dermal (collagen/fibronectin/laminin) and epidermal (desmosome) structures simultaneously.

**Mechanism of action:** In fibroblast cell culture studies, Hexapeptide-11 has been shown to increase gene and protein expression of: - **Collagen type I**: The primary structural collagen of dermis - **Fibronectin**: An adhesive glycoprotein that mediates cell-matrix attachment and wound healing - **Laminin**: A basement membrane glycoprotein critical for dermal-epidermal junction integrity

In keratinocyte cultures, it upregulates

  • **Desmoplakin (DSP)** and **desmoglein (DSG)**: Components of desmosomes — specialized cell-cell junctions that provide mechanical cohesion to the epidermis

**Clinical cosmetic evidence:** A double-blind, vehicle-controlled clinical study of 0.5% Hexapeptide-11 applied twice daily for 8 weeks showed statistically significant improvements in skin firmness (cutometer measurement) and skin texture scores vs placebo group. Additional consumer studies showed subjective improvement in skin smoothness and density.

**Comparison to other ECM peptides:** Unlike palmitoyl peptides (Matrixyl, GHK-Cu) which primarily target TGF-β and TIMP pathways, Hexapeptide-11 appears to work through distinct pathways (not primarily TGF-β dependent), making it potentially additive when combined with palmitoyl pentapeptide-4 or GHK-Cu in multi-peptide formulations.

Key Research Benefits

Documented effects observed in preclinical and clinical studies on Hexapeptide-11. See all Skin & Anti-Aging peptides for comparison.

Stimulates fibroblast synthesis of collagen, fibronectin, and laminin — structural ECM proteins critical for skin firmness
Upregulates desmosome proteins (DSP, DSG) — reinforces cell-cell adhesion in the epidermis
Improves skin mechanical properties and resistance to deformation — measured by cutometry in clinical studies
Anti-aging activity via multiple ECM stimulatory pathways simultaneously (vs peptides targeting a single protein)
Biofermentation origin — derived from Saccharomyces cerevisiae fermentation, providing a natural ingredient profile

Side Effects & Risks

Adverse effects reported in the research literature. All data sourced from preclinical and clinical study reports.

Excellent tolerability profile; no significant sensitization or irritation in cosmetic use
Very low molecular weight peptide — good penetration potential in aqueous delivery systems

Dosing Data from the Literature

Doses referenced below are sourced from published preclinical and clinical studies. Use the peptide dose calculator to convert these values to injection volume.

Research Dosing Protocol

Cosmetic formulation concentrations:

Standard range: 0.01-0.5% (active is potent — lower concentrations are often effective) Anti-aging formulations: 0.1-0.5% in serums and moisturizers Clinical studies: 0.5% demonstrated statistically significant improvements in skin firmness vs placebo at 4 and 8 weeks

Enter your vial size and target dose to get the exact injection volume.

Administration in Research Settings

Standard reconstitution and administration methodology for laboratory research use.

Applied topically in serums, moisturizers, or treatment creams. Compatible with most cosmetic active ingredients. Stable in formulations at pH 5-7.

Explore Further

Quick Reference

Molar Mass
735.90 g/mol
Formula
C36H57N7O8S
Legal Status
Cosmetic ingredient (INCI: Hexapeptide-11). Regulated as a cosmetic active ingredient globally.
Storage
Store formulations containing Hexapeptide-11 at 4-25°C, away from light. Dry powder: store at room temperature, sealed, protected from moisture.

Research Use Only

This information is for educational research purposes only. This is not medical advice. Consult a qualified healthcare professional.